[1]
Monsonego, S. 2023. The Use of Biosimilar Insulins in 2023. Canadian Diabetes & Endocrinology Today. 1, 1 (Mar. 2023), 21–25. DOI:https://doi.org/10.58931/cdet.2023.118.